Canada Markets close in 55 mins

HAVN Life Sciences Inc. (HAVLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1880+0.0091 (+5.09%)
As of 01:55PM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.9800
52 Week Low 30.1510
50-Day Moving Average 30.2010
200-Day Moving Average 30.4091

Share Statistics

Avg Vol (3 month) 386.04k
Avg Vol (10 day) 359.36k
Shares Outstanding 589.94M
Implied Shares Outstanding 6N/A
Float 883.23M
% Held by Insiders 11.09%
% Held by Institutions 12.03%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Apr. 29, 2020
Most Recent Quarter (mrq)Jan. 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-486.91k
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.34M
Total Cash Per Share (mrq)0.15
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)47.25
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-900.18k
Levered Free Cash Flow (ttm)N/A